Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
01 5Vyepti
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 15
2019 Revenue in Millions : 0
Growth (%) : New Launch
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 75
2020 Revenue in Millions : 15
Growth (%) : 429
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 145
2021 Revenue in Millions : 75
Growth (%) : 93
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 244
2022 Revenue in Millions : 145
Growth (%) : 69
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 403
2023 Revenue in Millions : 244
Growth (%) : 65
